• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素上皮细胞和视网膜下间隙的免疫抑制特性。

Immunosuppressive properties of the pigmented epithelial cells and the subretinal space.

作者信息

Zamiri Parisa, Sugita Sunao, Streilein J Wayne

机构信息

Schepens Eye Research Institute, Harvard Medical School, Boston, Mass., USA.

出版信息

Chem Immunol Allergy. 2007;92:86-93. doi: 10.1159/000099259.

DOI:10.1159/000099259
PMID:17264485
Abstract

The immune privilege of the anterior chamber of the eye has been recognized for over 100 years. However, the unique immunological properties of the pigmented epithelial (PE) cells of the eye and the subretinal space (SRS) have only recently been appreciated. The PE cells of the iris, ciliary body, and retina reside in anatomically disparate locations and serve distinctly different functions, yet share interesting immunomodulatory properties that contribute to ocular immune privilege. PE cells in the ciliary body and retina elaborate a variety of soluble factors that either directly or indirectly dampen immune-mediated inflammation; these include transforming growth factor-Beta, somatostatin, thrombospondin and pigment epithelial derived factor (PEDF). The constitutive expression of the immune co-stimulatory molecule, CD86, on iris PE cells not only inhibits T cell proliferation, but also promotes the generation of regulatory T cells. The SRS is now recognized as an immune-privileged site that shares many, but not all, of the properties ascribed to the anterior chamber, including the induction of systemic immune deviation. The prospect of therapeutic retinal transplantation and the possible immunologic etiology for some forms of age-related macular degeneration provides new impetus for gaining a better understanding of ocular immune privilege in the posterior regions of the eye.

摘要

眼睛前房的免疫赦免已被认识超过100年。然而,眼部色素上皮(PE)细胞和视网膜下间隙(SRS)独特的免疫学特性直到最近才被认识到。虹膜、睫状体和视网膜的PE细胞位于解剖学上不同的位置,发挥着截然不同的功能,但却具有有趣的免疫调节特性,这些特性有助于眼部的免疫赦免。睫状体和视网膜中的PE细胞会产生多种可溶性因子,这些因子直接或间接抑制免疫介导的炎症;其中包括转化生长因子-β、生长抑素、血小板反应蛋白和色素上皮衍生因子(PEDF)。虹膜PE细胞上免疫共刺激分子CD86的组成性表达不仅抑制T细胞增殖,还促进调节性T细胞的产生。SRS现在被认为是一个免疫赦免部位,它具有许多(但不是全部)归因于前房的特性,包括诱导全身免疫偏离。治疗性视网膜移植的前景以及某些形式的年龄相关性黄斑变性可能的免疫病因,为更好地理解眼后部区域的眼部免疫赦免提供了新的动力。

相似文献

1
Immunosuppressive properties of the pigmented epithelial cells and the subretinal space.色素上皮细胞和视网膜下间隙的免疫抑制特性。
Chem Immunol Allergy. 2007;92:86-93. doi: 10.1159/000099259.
2
Thrombospondin plays a vital role in the immune privilege of the eye.血小板反应蛋白在眼睛的免疫赦免中起着至关重要的作用。
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):908-19. doi: 10.1167/iovs.04-0362.
3
Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms.色素上皮在眼免疫赦免中的作用。3. 从虹膜、睫状体和视网膜培养的上皮细胞通过部分不重叠的机制抑制T细胞活化。
Ocul Immunol Inflamm. 2003 Jun;11(2):91-105. doi: 10.1076/ocii.11.2.91.15914.
4
Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta.视网膜和睫状体色素上皮通过转化生长因子β抑制T淋巴细胞的激活。
Exp Eye Res. 2006 Dec;83(6):1459-71. doi: 10.1016/j.exer.2006.08.005. Epub 2006 Sep 22.
5
Ocular immune privilege sites.眼免疫赦免部位
Methods Mol Biol. 2011;677:449-58. doi: 10.1007/978-1-60761-869-0_28.
6
Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.表达CD86(B7-2)的虹膜色素上皮细胞通过与细胞毒性T淋巴细胞相关抗原4结合,在体外直接抑制T细胞活化。
J Exp Med. 2003 Jul 7;198(1):161-71. doi: 10.1084/jem.20030097. Epub 2003 Jun 30.
7
Role of ocular pigment epithelial cells in immune privilege.眼色素上皮细胞在免疫赦免中的作用。
Arch Immunol Ther Exp (Warsz). 2009 Jul-Aug;57(4):263-8. doi: 10.1007/s00005-009-0030-0. Epub 2009 Jul 1.
8
Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells.血小板反应蛋白-1在T细胞对眼色素上皮细胞反应中的作用。
J Immunol. 2007 Jun 1;178(11):6994-7005. doi: 10.4049/jimmunol.178.11.6994.
9
Immune Privilege and Eye-Derived T-Regulatory Cells.免疫特权与眼源 T 调节细胞
J Immunol Res. 2018 May 20;2018:1679197. doi: 10.1155/2018/1679197. eCollection 2018.
10
Immunological homeostasis of the eye.眼的免疫学稳态。
Prog Retin Eye Res. 2013 Mar;33:10-27. doi: 10.1016/j.preteyeres.2012.10.002. Epub 2012 Oct 26.

引用本文的文献

1
Metabolic stress and early cell death in photoreceptor precursor cells following retinal transplantation.视网膜移植后光感受器前体细胞中的代谢应激与早期细胞死亡
Stem Cell Res Ther. 2025 Jul 25;16(1):397. doi: 10.1186/s13287-025-04509-w.
2
Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration.在早期年龄相关性黄斑变性中,视网膜变性之前,外视网膜微炎症是由T细胞反应驱动的。
Front Immunol. 2025 Feb 5;16:1520188. doi: 10.3389/fimmu.2025.1520188. eCollection 2025.
3
Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease.
基于光感受器细胞的退行性视网膜疾病治疗的最新进展
Stem Cells Transl Med. 2024 Apr 15;13(4):332-345. doi: 10.1093/stcltm/szae005.
4
INFLAMMATORY CELL ACTIVITY IN TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Histologic Case Study.治疗新生血管年龄相关性黄斑变性中的炎症细胞活性:一项组织病理学案例研究。
Retina. 2023 Nov 1;43(11):1904-1913. doi: 10.1097/IAE.0000000000003881.
5
Impaired Immunomodulatory Properties of the Retina from the Inflammatory Environment of the Damaged Eye.受损眼部炎症环境导致视网膜免疫调节特性受损。
Inflammation. 2023 Dec;46(6):2320-2331. doi: 10.1007/s10753-023-01880-9. Epub 2023 Aug 15.
6
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.SAR422459(EIAV-ABCA4)基因治疗在 ABCA4 相关性 Stargardt 病患者中的 3 年安全性结果:一项开放标签剂量递增 I/IIa 临床试验,队列 1-5。
Am J Ophthalmol. 2022 Aug;240:285-301. doi: 10.1016/j.ajo.2022.02.013. Epub 2022 Mar 4.
7
Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration.全身性给药后小鼠眼内单克隆抗体和抗体片段的药代动力学。
AAPS J. 2021 Nov 8;23(6):116. doi: 10.1208/s12248-021-00647-0.
8
Retinal Lineage Therapeutic Specific Effect of Human Orbital and Abdominal Adipose-Derived Mesenchymal Stem Cells.人眼眶和腹部脂肪来源间充质干细胞的视网膜谱系治疗特异性效应
Stem Cells Int. 2021 Oct 19;2021:7022247. doi: 10.1155/2021/7022247. eCollection 2021.
9
Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.基于细胞的视网膜疾病疗法:临床试验和直接面向消费者的“细胞疗法”诊所综述。
Stem Cell Res Ther. 2021 Oct 11;12(1):538. doi: 10.1186/s13287-021-02546-9.
10
Ocular Inflammation and Treatment Emergent Adverse Events in Retinal Gene Therapy.视网膜基因治疗中的眼部炎症及治疗突发不良事件
Int Ophthalmol Clin. 2021 Jul 1;61(3):151-177. doi: 10.1097/IIO.0000000000000366.